RPG Life Sciences Ltd (RPGLIFE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 456242,
    "name": "RPG LifeScience.",
    "stock_name": "RPG LifeScience.",
    "full_name": "RPG Life Sciences Ltd",
    "name_url": "stocks-analysis/rpg-lifescience",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,898.90",
    "chg": -134.65,
    "chgp": "-4.44%",
    "dir": -1,
    "prev_price": "3,033.55",
    "mcapval": "4,960.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532983,
    "symbol": "RPGLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE105J01010",
    "curr_date": "Sep 24, 03:30 PM",
    "curr_time": "19:41 PM",
    "last_traded_at": "Sep 24, 03:30 PM IST",
    "bse_nse_vol": "65.74 k",
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/rpg-lifescience-456242-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "RPG Life Sciences Ltd Surges 7.08% to Day's High of Rs 2950 — Outperforms Sector by 6.24 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-hits-intraday-high-with-708-surge-on-23-sep-2026-4202692",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/RPGLifeSciences_priceRelatedfactors_4202692.png",
        "date": "2026-09-23 14:31:27",
        "description": "The Sensex advanced 0.52% on 23 Sep 2026, yet RPG Life Sciences Ltd outpaced the broader market with a 7.08% gain, reaching an intraday high of Rs 2950. This 6.24 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "RPG Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rpg-life-sciences-ltd-is-rated-hold-4202416",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/RPGLifeSciences_mojoScore_4202416.png",
        "date": "2026-09-23 10:10:25",
        "description": "RPG Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 September 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "RPG Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rpg-life-sciences-ltd-is-rated-hold-4191096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/RPGLifeSciences_mojoScore_4191096.png",
        "date": "2026-09-12 10:10:14",
        "description": "RPG Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "RPG Life Sciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4189746",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/RPGLifeSciences_technicaldot_4189746.png",
        "date": "2026-09-11 08:01:56",
        "description": "RPG Life Sciences Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of mid-2026. Despite a recent downgrade in daily price performance, the stock’s monthly and weekly technical indicators present a complex picture, reflecting both strength and caution for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "RPG Life Sciences Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-technical-momentum-shifts-signal-bullish-outlook-4188504",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/RPGLifeSciences_technicaldot_4188504.png",
        "date": "2026-09-10 08:01:55",
        "description": "RPG Life Sciences Ltd has demonstrated a notable shift in price momentum and technical indicators, signalling a transition from a mildly bullish to a more confident bullish trend. This change is underscored by improvements in moving averages and Bollinger Bands, alongside mixed signals from MACD and KST indicators, suggesting a nuanced but positive outlook for this small-cap pharmaceutical player."
      },
      {
        "title": "RPG Life Sciences Ltd Valuation Shifts Signal Changing Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-valuation-shifts-signal-changing-price-attractiveness-4181680",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/RPGLifeSciences_valuationdot_4181680.png",
        "date": "2026-09-04 08:00:25",
        "description": "RPG Life Sciences Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting evolving market perceptions and price attractiveness. Despite this, the stock continues to outperform the Sensex over multiple time horizons, prompting a detailed analysis of its current price metrics against historical and peer benchmarks."
      },
      {
        "title": "RPG Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rpg-life-sciences-ltd-is-rated-hold-4177859",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/RPGLifeSciences_mojoScore_4177859.png",
        "date": "2026-09-01 10:10:04",
        "description": "RPG Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 September 2026, providing investors with an up-to-date perspective on the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "RPG Life Sciences Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rpg-life-sciences-ltd-technical-momentum-shifts-to-mildly-bullish-amid-mixed-indicators-4169375",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/RPGLifeSciences_technicaldot_4169375.png",
        "date": "2026-08-26 08:02:02",
        "description": "RPG Life Sciences Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-2026. Despite a slight dip in daily price, the stock’s technical indicators present a nuanced picture, with some metrics signalling strength while others suggest caution. This article analyses the recent technical parameter changes, key momentum indicators, and the stock’s performance relative to the broader market."
      },
      {
        "title": "RPG Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rpg-life-sciences-ltd-is-rated-hold-4164056",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/RPGLifeSciences_mojoScore_4164056.png",
        "date": "2026-08-21 10:10:03",
        "description": "RPG Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      }
    ],
    "total": 426,
    "sid": "456242",
    "stock_news_url": "https://www.marketsmojo.com/news/rpg-life-sciences-456242"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "17-Sep-2026",
      "details": "Intimation of Analysts/Institutional Investors Meet",
      "source": "BSE"
    },
    {
      "caption": "Update On Business Transfer Agreement By RPGAP",
      "datetime": "15-Sep-2026",
      "details": "Update on completion of BTA execution by RPG Active Pharma Limited with Raghava Life Sciences Private Limited",
      "source": "BSE"
    },
    {
      "caption": "Update On Investment And Shareholder Agreement",
      "datetime": "09-Sep-2026",
      "details": "update on Investment and Shareholders Agreement entered on July 29 2026 subsidiary of the company allotted securities to the Investors.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "RPG Life Sciences Ltd has declared <strong>300%</strong> dividend, ex-date: 09 Jul 26",
          "dt": "2026-07-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

RPG Life Sciences Ltd Surges 7.08% to Day's High of Rs 2950 — Outperforms Sector by 6.24 Percentage Points

2026-09-23 14:31:27

The Sensex advanced 0.52% on 23 Sep 2026, yet RPG Life Sciences Ltd outpaced the broader market with a 7.08% gain, reaching an intraday high of Rs 2950. This 6.24 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

RPG Life Sciences Ltd is Rated Hold

2026-09-23 10:10:25

RPG Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 September 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

RPG Life Sciences Ltd is Rated Hold

2026-09-12 10:10:14

RPG Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

RPG Life Sciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-11 08:01:56

RPG Life Sciences Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of mid-2026. Despite a recent downgrade in daily price performance, the stock’s monthly and weekly technical indicators present a complex picture, reflecting both strength and caution for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

RPG Life Sciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-09-10 08:01:55

RPG Life Sciences Ltd has demonstrated a notable shift in price momentum and technical indicators, signalling a transition from a mildly bullish to a more confident bullish trend. This change is underscored by improvements in moving averages and Bollinger Bands, alongside mixed signals from MACD and KST indicators, suggesting a nuanced but positive outlook for this small-cap pharmaceutical player.

Read full news article

RPG Life Sciences Ltd Valuation Shifts Signal Changing Price Attractiveness

2026-09-04 08:00:25

RPG Life Sciences Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting evolving market perceptions and price attractiveness. Despite this, the stock continues to outperform the Sensex over multiple time horizons, prompting a detailed analysis of its current price metrics against historical and peer benchmarks.

Read full news article

RPG Life Sciences Ltd is Rated Hold

2026-09-01 10:10:04

RPG Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 September 2026, providing investors with an up-to-date perspective on the company’s fundamentals, returns, and market standing.

Read full news article

RPG Life Sciences Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Indicators

2026-08-26 08:02:02

RPG Life Sciences Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-2026. Despite a slight dip in daily price, the stock’s technical indicators present a nuanced picture, with some metrics signalling strength while others suggest caution. This article analyses the recent technical parameter changes, key momentum indicators, and the stock’s performance relative to the broader market.

Read full news article

RPG Life Sciences Ltd is Rated Hold

2026-08-21 10:10:03

RPG Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

View All News